Novo Nordisk gains approval to sell weight-loss drug Wegovy in China 25 de junho de 2024 by in News Europe’s most valuable company said Chinese regulators have approved its marketing application to sell Wegovy as a long-term weight-loss treatment for patients with obesity. Compartilhe isso:Clique para compartilhar no Twitter(abre em nova janela)Clique para compartilhar no Facebook(abre em nova janela) Relacionado 25 de junho de 2024